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Induction of Myocarditis and Valvulitis in Lewis Rats
by Different Epitopes of Cardiac Myosin and Its
Implications in Rheumatic Carditis

Jeffrey E. Galvin,* Mark E. Hemric,*
Stanley D. Kosanke,t Stephen M. Factor,+
Anthony Quinn,* and Madeleine W. Cunningham*
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Patho!oR)"t Uniuersit), 0/ Oklahoma Health Sciences Cellter,
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Immune responses against cardiac myosin and group
A streptococcal M protein have been implicated in the
pathogenesis of rheumatic heart disease. Although
cardiac myosin is known to produce myocarditis in
susceptible animals, it has never been investigated for
its role in production of valvular heart disease, the
most serious sequelae of group A streptococcal infection in acute rheumatic fever. In our study, cardiac
myosin induced valvulitis in the Lewis rat, and
epitopes responsible for production of valvulitis were
located in the rod region. Human and rat cardiac
myosins induced severe myocarditis in the Lewis rats
as expected. A purified S2 fragment (amino acid sequences 842 to 1295) produced the most severe myocarditis as well as valvulitis. Different regions of light
meromyosin produced valvulitis (residues 1685 to
1936) or myocarditis (residues 1529 to 1611). Because
streptococcal M proteins produced valvular heart disease in Lewis rats and have been linked to anti-cardiac
myosin responses, we reacted myosin-sensitized lymphocytes isolated from the hearts of Lewis rats with
peptides of streptococcal M5 protein in tritiated thymidine assays. Inf'tltrating lymphocytes responded
most strongly to peptides within the B repeat region
of streptococcal M protein. These data show direct
evidence that immune responses against cardiac myosin lead to valvular heart disease and the inf'tltration
of the heart by streptococcal M protein reactive T
lymphocytes. (AmJ Patho12002, 160:297-306)

is cardiac myosin, 2513 ln 1985, myosin was identified as
an autoantigen involved in cross-reactivity between the
group A streptococcus and heart,14 Since this time, evidence has supported the molecular mimicry hypothesis
that streptococcal M protein and the group A carbohydrate both induce anti-myosin responses that attack the
heart.715-19 Rheumatic carditis and myocarditis may
have similar pathogenic mechanisms because immunological mimicry was demonstrated between streptococcal M protein and myocarditic coxsackieviruses and both
were associated with cytotoxic antibody against heart
cells as well as T-Iymphocyte responses,18,20-22 Peptides of streptococcal M protein were shown to produce
myocarditis in mice 7 and intact recombinant streptococcal M protein produced valvular heart disease in Lewis
rats, 17 Studies also suggested that a myocarditic peptide
of streptococcal M protein, which mimics cardiac myosin,
tolerated and protected MRL/+ + mice against autoimmune myocarditis after coxsackieviral infection 23 However, it is debated as to whether or not mimicry between
coxsackieviruses and cardiac myosin plays a role in the
pathogenesis of myocarditis,24,25
There is strong evidence that cardiac myosin is a dominant autoantigen in autoimmune myocarditis8 and viral-induced myocarditis,10 Investigators have demonstrated that
myosin-induced myocarditis can be adoptively transferred
by CD4+ T lymphocytes,12 In addition to T cells, passive
administration of anti-myosin monoclonal antibody was
found to induce myocarditis in DBA/2 but not BALB/c mice
because of the presence of myosin or a myosin-like protein
in the extracellular matrix of DBN2 mice,26 Gauntt and
colleagues 27 - 29 investigated the relationship between coxsackievirus and myosin and suggested that molecular mimicry between myosin and coxsackieviruses may playa role
in myocarditis, Anti-coxsackieviral-neutralizing antibody
produced myocardial inflammation in mice,27 In rheumatic
carditis, group A streptococcal infection plays a major role
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Infectious pathogens, including viruses,1 group A streptococci,2 or chlamydia 3 are important etiological agents
of inflammatory heart disease, However, immune and
specifically autoimmune mechanisms are the major effectors of pathogenic inj ury 4 The autoantigen most often
associated with both myocarditis and rheumatic carditis
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and anti-myosin antibody is associated with disease 3031
Monoclonal anti-myosin antibody has been shown to be
cytotoxic for heart cells in culture and was found to recognize laminin on the valve and myocyte cell surface. 15 ,16
Antibodies in rheumatic carditis deposit in myocardium as
well as valvular endothelium,16,32,33 and streptococcal M
protein reactive T cells were found in human rheumatic
valves 34 Thus, in inflammatory heart diseases, myocarditis,
and rheumatic carditis, both antibody and T cells are implicated in the disease.
Although valvulitis is the most serious complication of
rheumatic fever and leads to the development of rheumatic heart disease,35 animal models of valvulitis have
not been previously investigated. In addition, the role of
cardiac myosin in valvular heart disease has not been
previously addressed. In our study, we identified
epitopes in human cardiac myosin (HCM) that induced
valvulitis in Lewis rats. In the light meromyosin (LMM)
region, myocarditis- and valvulitis-inducing epitopes
could be separated, but the S2 rod fragment produced
both myocarditis and valvulitis. Our data show that valvulitis was induced by immunization with cardiac myosin,
cardiac myosin subfragments, heavy meromyosin
(HMM), or S2, and with one region in LMM that was
different from a site in LMM that produced myocarditis.
Furthermore, lymphocytes isolated from the hearts of
Lewis rats with myocarditis and valvulitis proliferated in
the presence of specific streptococcal M5 protein peptides. These data show direct evidence that immune
responses against cardiac myosin can induce valvular
heart disease and the infiltration of the heart by streptococcal M protein-reactive T lymphocytes.

Materials and Methods

Antigens
Bovine serum albumin, rabbit skeletal tropomyosin, rabbit skeletal HMM, and rabbit skeletal LMM were purchased from Sigma Chemical Co., St. Louis, MO. Peptides from the LMM region of HCM and the streptococcal
M5 protein were synthesized on a Dupont RAMPS manual peptide synthesizer using the f-moc strategy by the
Molecular Biology Resource Center at the University of
Oklahoma Health Sciences Center, Oklahoma City, OK
(Dr. Ken Jackson, Director). Peptides were synthesized
as 18-mers with a five-amino acid overlap. The streptococcal M5 peptides represented the sequence of the
type 5 streptococcal M protein of the Streptococcus pyogenes (Manfraedo strain). The amino acid sequences of
the human cardiac LMM peptides are shown in Table 1
and the streptococcal M5 peptides are shown in Table 2.

Myosin Purification
Cardiac myosin was purified from human (HCM) and rat
(RCM) heart tissue, and human skeletal myosin was purified from human quadriceps tissue according to Tobacman and colleagues 36 with slight modifications. Briefly,
heart tissue was homogenized in a low salt buffer [40

Table 1.

Human Cardiac Light Meromyosin Peptides

Peptide no.
LMM-1
LMM-2
LMM-3
LMM-4
LMM-5
LMM-6
LMM-7
LMM-S
LMM-9
LMM-10
LMM-11
LMM-12
LMM-13
LMM-14
LMM-15
LMM-16
LMM-17
LMM-18
LMM-19
LMM-20
LMM-21
LMM-22
LMM-23
LMM-24
LMM-25
LMM-26
LMM-27
LMM-28
LMM-29
LMM-30
LMM-31
LMM-32
LMM-33
LMM-34
LMM-35
LMM-36
LMM-37
LMM-38
LMM-39
LMM-40
LMM-41
LMM-42
LMM-43
LMM-44
LMM-45
LMM-46
LMM-47
LMM-48
LMM-49

Amino acid sequence

Residue no.

KEALISSL TRGKLTYTOO
TYTOOLEDLKROLEEEVK
EEEVKAKNALAHALOSAR
LOSARHDCDLLREOYEEE
EOYEEETEAKAELORVLSK
RVLSKANSEVAOWRTKYE
RTKYETDAIORTEELEEA
ELEEAKKKLAORLOEAEE
OEAEEAVEAVNAKCSSLE
CSSLEKTKHRLONEIEDL
EI EDLMVDVERSNAAAAA
AAAAALDKKORNFDKILA
DKILAEWKOKYEESOSEL
SOSELESSOKEARSLSTE
SLSTELFKLKNAYEESLE
EESLEHLETFKRENKNLO
NKNLOEEISDLTEOLGSS
EOLGSSGKTIHELEKVRKO
KVRKOLEAEKMELOSALE
LOSALEEAEASLEHEEGKI
EEG KI LRAOLEFNOI KAE
NOI KAEI ERKLAEKDEEME
DEEMEOAKRNHLRVVDSL
VVDSLOTSLDAETRSRNE
RSRNEALRVKKKMEGDLN
EGDLNEMEIOLSHANRMA
ANRMAAEAOKOVKSLOSL
SLOSLLKDTO IOLDDAVR
RANDDLKENIAIVERRNN
IAIVERRNNLLOAELEEL
ELEELRAVVEOTERSRKL
RSRKLAEOELI ETSERVO
SERVOLLHSONTSLINOK
LlNOKKKMDADLSOLOTE
TEVEEAVOESRNAEEKAKK
RNAEEKAKKAITDAAMMA
AAMMAEELKKEODTSAHL
TSAHLERMKKNMEOTIKDL
TI KDLOHRLDEAEO IALK
EOIALKGGKKOLOKLEARV
LEARVRELENELEAEOKR
AEOKRNAESVKGMRKSER
RKSERRIKEL TYOTEEDR
TEEDRKNLLRLODLVDKL
LVDKLOLKVKAYKROAEE
ROAEEAEEOANTNLSKFR
LSKFRKVOHELDEAEERA
AEERADIAESOVNKLRAK
KLRAKSRDIGTKGLNEE

1295-1312
1308-1325
1321-1338
1334-1351
1346-1364
1360-1376
1373-1390
1386-1403
1399-1416
1412-1429
1425-1442
1438-1455
1451-1468
1464-1481
1477-1494
1490-1507
1503-1520
1516-1533
1529-1546
1542-1559
1555-1572
1568-1585
1581-1598
1594-1611
1607-1624
1620-1637
1633-1650
1646-1663
1659-1676
1672-1689
1685-1702
1698-1715
1711-1728
1724-1741
1737-1754
1750-1767
1763-1780
1777-1794
1790-1807
1802-1820
1816-1833
1829-1846
1842-1859
1855-1872
1868-1885
1881-1898
1894-1910
1907-1923
1920-1936

mmol/L KCI, 20 mmol/L imidazole (pH-7.0), 5 mmol/L
EGTA, 5 mmol/L dithiothreitol, 0.5 mmol/L phenylmethyl
sulfonyl fluoride (PMSF), and 1 /-tg/ml leupeptin] for 15
seconds on ice. The washed myofibrils were collected by
centrifugation at 16,000 x g for 10 minutes. The myofibrils were then resuspended in high-salt buffer (0.3 mol/L
KCI, 0.15 mol/L K2HP0 4, 1 mmol/L EGTA, 5 mmol/L dithiothreitol, 0.5 mmol/L PMSF, and 1 /-tg/mlleupeptin) and
homogenized for three 30-second bursts on ice. The
homogenized tissue was further incubated on ice with
stirring for 30 minutes to facilitate actomyosin extraction.
After clarification by centrifugation, actomyosin was precipitated by adding 10 volumes of cold water and adjustment of the pH to 6.5. Dithiothreitol was added to 5
mmol/L and the precipitation allowed to proceed for 30
minutes. The actomyosin was then collected by centrifu-

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Cardiac Myosin Epitopes in Myocarditis and Valvulitis
299
AIP January 2002, Vol, 160, No, 1

Table 2.

Amino Acid Sequence of Type 5 M Protein
Peptides'

NT-1t
NT-2
NT-3
NT-4
NT-5
NT-6
NT-7
NT-8
B1-A
B1-B
B1-B2
B2
B2-B3A
B3A
B2-B3B
B3B
C1A
C1B
C1-C2
C2A
C2B
C2-C3
C3

AVTRGTINDPORAKEALD
KEALDKYELENHDLKTKN
LKTKNEGLKTENEGLKTE
GLKTENEGLKTENEGLKTE
KKEHEAENDKLKOORDTL
ORDTLSTOKETLEREVON
REVONTOYNNETLKIKNG
KIKNGDLTKELNKTROEL
TROELANKOOESKENEKAL
ENEKALNELLEKTVKDKI
VKDKIAKEOENKETIGTL
TIGTLKKILDETVKDKIA
KDKIAKEOBNKETIGTLK
ITGLKKILDETVKDKLAK
DKLAKEOKSKONIGALKO
GALKOELAKKDEANKISD
NKISDASRKGLRRDLDAS
DLDASREAKKOLEAEHKO
AEHOKLEEONKISEASRK
EASRKGLRRDLDASREAK
SREAKKOLEAEOOKLEEO
KLEEONKISEASRKGLRR
KGLRRDLDASREAKKO

-Predicted amino acid sequence of serotype 5 M protein from S,
pyogenes, strain Manfredo,

tpeptides represent the sequence found in the amino terminal
region (NT), and 8 (8) and C (C) repeat regions of the M5 protein.

gation at 16,000 x g, The actomyosin pellet was then
resuspended in high-salt buffer, ammonium sulfate was
increased to 33%, and the KCI concentration was increased to 0,5 mol/L, After the actomyosin pellet and
salts were dissolved, ATP was added to 10 mmol/L,
MgCI2 was added to 5 mmol/L, and the solution was
centrifuged at 20,000 x g for 15 minutes to remove actin
filaments, The supernatant was removed and stored at
4°C in the presence of the following inhibitors: 0,5 mmol/L
PM SF, 5 p,g/ml TLCK, and 1 p,g/ml leupeptin,

Isolation of Cardiac Myosin Fragments
The myosin molecule can be divided into subfragments
through proteolysis, At lower ionic strengths, chymotryptic cleavage yields subfragment-1 (S1) and myosin rod;
whereas, at higher ionic strength, chymotryptic cleavage
yields HMM and LMM, Further cleavage of HMM yields
S1 and S2 subfragments, Purified subfragments and synthetic LMM peptides from HCM that were tested in Lewis
rats are shown in Figure 1, Purity of all proteins was
assessed using sodium dodecyl sulfate-polyacrylamide
gel electrophoresis, and in some cases, fragments required further purification by ammonium sulfate precipitation and/or diethyl amino ethyl ion exchange chromatography,

Human Myosin Subfragment-1
In our studies, S1 was produced from purified HCM according to Tobacman and colleagues 36 with slight modification, Briefly, myosin was dialyzed against digestion
buffer (0,1 mol/L NaCI, 0,01 mol/L imidazole-HCI, pH 7,
and 0,001 mol/L dithiothreitol) and cleaved with a 1: 100

Cardiac myosin

842

1295

1936

I

I

I

1295
I

HMM

842

I

SI
596
S2

1295

I

I

1295

LMM peptide groups

L---__

1936

J

Figure 1. Diagram of HCM, cardiac myosin subfragments, and LMM peptide
groups, H:VI:V1. subfragment-l (51), and subfragment-2 (S2) were enzymatically cleaved and purified as described in Malerials and Methods and as
shown in the diagram, Each of the eight L:V1M peptide groups consisted of six
consecutive, overlapping, synthetic peptides. The LMM peptides correspond
to the LMM region of HCM as shown,

w/w ratio of a-chymotrypsin to myosin for 15 minutes at
25°C, The reaction was terminated by the addition of
PMSF to a final concentration of 0,3 mmol/L, The rod and
uncleaved myosin were precipitated by dialysis in a low
salt solution (10 mmol/L NaCI, 10 mmol/L imidazole, pH
7,0, 1 mmol/L dithiothreitol) and then separated from the
soluble S1 by centrifugation at 20,000 X g,

Human Cardiac HMM
The HMM subfragment of HCM was prepared according
to a previously described procedure with slight modifications,37 Briefly, HMM was prepared by digesting myosin
with a chymotrypsin 100:1 w/w ratio in 0,6 mol/L KCI, 2
mmol/L MgCI 2, 1 mmol/L dithiothreitol, and 0,01 mol/L
Tris-HCI (pH 7,6) for 10 minutes at 25°C, The reaction
was terminated by adding PMSF to a final concentration
of 0,2 mmol/L, The LMM and uncleaved myosin were
precipitated by dialysis in a low-salt solution (0,03 mol/L
KCI, 0,01 mol/L potassium phosphate, pH 6,3, 1 mmol/L
dithiothreitol, and 1 mmol/L MgCI 2 ) and then separated
from the soluble HMM by centrifugation at 20,000 x g,

S2 Fragment of Human Cardiac Myosin
Normally, S2 subfragment of cardiac myosin was prepared by controlled proteolysis of purified HMM subfragmen!. However, in these studies, an S2-containing fragment was produced from purified preparations of human
cardiac HMM that seemed to be proteolyzed by an innate
protease, The S2 fragment was purified by applying the
innately proteolyzed preparation of HMM to S-400 gel
filtration chromatography, Identity of S2 was confirmed
by N-terminal sequencing using the Edman degradation
method, Myosin subfragments are shown in a diagram in
Figure 1,

Immunization
Female Lewis rats (6- to 8-weeks old) were purchased
from Harlan-Sprague-Oawley (Indianapolis, IN) and
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maintained in groups of three or four at the Animal Resources Facility on the campus of the University of Oklahoma Health Sciences Center, Five hundred p,g of protein or peptide was emulsified in Freund's complete
adjuvant at a 1: 1 ratio (v/v) and injected into one hind
footpad of rats anesthetized with 10 mg of ketamine/0.2
mg of xylazine. On days 1 and 3 after immunization, the
rats were intraperitoneally administered 1 x 10 10 killed
Bordetella pertussis organisms as an adjuvant. Seven
days after the primary immunization rats were boosted
subcutaneously with 500 p,g of protein or peptide emulsified in Freund's incomplete adjuvant (1:1 ratio), Control
rats received phosphate-buffered saline (PBS) or bovine
serum albumin emulsified in Freund's adjuvant and B.
pertussis injections.

Histopathological Examination of Tissue
Rats were terminated 21 days after the primary immunization by cardiac puncture while under anesthesia.
Heart, liver, and kidneys were excised and fixed in 10%
buffered formalin. After routine tissue preparation (ie,
paraffin embedding, slide mounting, and hematoxylin
and eosin staining), myocardium was blindly scored for
the presence of histopathological myocarditis according
to the following scale: 0 = normal, 1 = mild «5% of heart
cross-section involved), 2 = moderate (5 to 10% of crosssection involved), 3 = marked (10 to 25% of cross-section involved), 4 = severe (>25% of cross-section involved). Valve tissue was observed for the presence of
cellular infiltrates. Liver and kidneys were also evaluated
for abnormalities, but were found to be normal.

Isolation and Proliferation Assay of
Lymphocytes Infiltrating Hearts in Cardiac
Myosin-Induced Myocarditis and Valvulitis
Inflamed hearts from Lewis rats with myocarditis/valvulitis
were perfused with heparinized Iscove's modified Dulbecco's medium, minced, and treated with collagenase
at 160 U/ml (Sigma Chemical Co) for 30 minutes at 37°C,
The tissue was then pressed through a screen to obtain a
single cell suspension and washed with Iscove's modified Dulbecco's medium, The cell suspension was separated in Ficoll Hypaque (Sigma Chemical Co.) and lymphocytes recovered after centrifugation. The cells were
washed in Iscove's modified Dulbecco's medium and
were resuspended in proliferation medium and reacted
with M5 peptides in the tritiated thymidine uptake assay
using 5 x 103 cells/well. To provide additional antigen
presenting cells,S x 103 mitomycin C-treated normal rat
spleen cells were added to each well. Proliferation medium consisted of Iscove's modified Dulbecco's medium,
2% rat serum, 50 p,mol/L 2-mercaptoethanol, 100 U penicillin, and 100 p,g streptomycin and streptococcal M5
peptide at 20 /Lg/ml. Wells were pulsed with 1.0 /LCi of
tritiated thymidine (ICN, Irvine, CAl 18 hours before being
harvested onto filters with a cell harvester. Tritiated thymidine incorporation was measured by a liquid scintilla-

Table 3.

Induction of :Vlyocarditis in Lewis Rats by
Immunization with Cardiac Myosin, Myosin
Suhfragments, or LMM Peptides

Immunogen
Whole molecule
Human cardiac myosin
Rat cardiac myosin
Subfragments of HCM
HMM subfragment of HCM
S 1 subfragment of HCM
S2 subfragment of HCMt
Related molecules and
fragments
Human skeletal myosin
Rabbit skeletal LMM
Rabbit skeletal HMM
Rabbit skeletal tropomyosin
Light meromyosin peptides
LMM peptides 1-6 t
LMM peptides 7-12
LMM peptides 13-18
LMM peptides 19-24
LMM peptides 25-30
LMM peptides 31-36
LMM peptldes 37-42
LMM peptides 43-49
Controls
Bovine serum albumin
PBS + adjuvants

Myocarditis
(positive/total)

Average
lesion
score*

18/23
13/13

3.0
3.4

5/5
0/7
3/3

4.0
0
3.8

0/6
0/5
0/3
0/6

0
0
0
0

1/9
1/6
0/6
5/11
0/6
0/6
0/4
0/6

2.5
0.5
0
2.0
0
0
0
0

0/6
0/34

0
0

'Lesions were scored histologically based on the following scale:
normal. 1 = mild (less than 5% of cross section involved). 2 =
moderate (5 to 10% of cross section Involved), 3 = marked (10-25% of
cross section involved), 4 = severe (greater than 25% 01 cross section
involved).
tNlnety live kd sublragment of human cardiac myosin containing the
S2 region as determined by Edman degradation.
+LMM peptide sequences are listed in Table 1

o=

tion counter. Values represent the stimulation index (stimulation index equals test counts per minute/media control
counts per minute).

Results
Induction of Myocarditis with Cardiac Myosin,
Subfragments, and LMM Pep tides
Lewis rats immunized with HCM developed severe clinical and histological myocarditis as expected (Table 3
and Figure 2a). This response was specific for the cardiac isoform as immunization with human skeletal myosin, rabbit skeletal LMM, and rabbit skeletal HMM did not
cause myocarditis (Table 3). Additionally, rabbit skeletal
tropomyosin, and bovine serum albumin did not induce
myocarditis (Table 3). Lewis rats immunized with rat cardiac myosin (RCM) developed myocarditis that was clinically and histologically indistinguishable from myocarditis induced by HCM (Table 3 and Figure 2b), Histological
lesions displayed intense inflammatory infiltrates consisting of lymphocytes, macrophages, neutrophils, and
multinucleated giant cells (Figure 2, a and b).
To confirm and extend knowledge about epitopes that
produce myocarditis in the Lewis rat, purified HCM sub-
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Figure 2. Histopathological feature-; uf autoimmune myocarditis in Lc\vis
rats. Ammals were immunized with HC"l (a). RCM (bJ. H"lM fragment of
HCM (e). S2 fragment of HC:VI td). HC"l L:VlM peptides 19 to 24 tel. and PBS
plus adjtl\ ants (f) as described in Material and Methods. Levlis rats in1n1Unized with human or RCM, LMM peptide group 19 to 24. HMM fragment, or
S2 fragment of HeM exhibit myocyte necro~is in the myocardium with
intense inflammatory infiltrates (a-e). Control rats in1l11unized with PBS plus
adjuvants (f) or \vith bovine serum albumin plus adjuvants (not sho\vn) have
no detectable histopathological 1c:-.ions. Original magnification,',,: X 200 (left
panels): X ,.00 (right panels).

fragments HMM. S1, and S2, were administered to Lewis
rats. HMM is a large subfragment of myosin comprised of
the S1 and 82 segments of the molecule (see diagram in
Figure 1). When administered to Lewis rats, HMM induced severe disease in 100% (five of five) of rats (Table
3, Figure 2c). All five animals had severe clinical signs of
disease, and the histopathological lesions were throughout a large portion of the heart and scored as severe
(Table 3). Immunization with the globular head or S1
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portion of the cardiac myosin molecule did not induce
myocarditis (Table 3), suggesting that disease-producing epitopes in the Lewis rat were confined to the rod
region.
To further analyze the rod region, an S2 fragment,
whose molecular mass was estimated at 95 kd by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, was
purified from human cardiac HMM. Edman degradation
sequence analysis of the first five amino acids of this
fragment revealed that the N terminus was at amino acid
residue 596 (sequence: KNKDP). Therefore, this HCM
fragment extended from amino acid residue 596 to residue 1295 (the C-terminal end of the HMM molecule) and
contained the entire S2 portion of the HCM molecule.
When administered to Lewis rats, the extended S2 subfragment of HCM induced severe myocarditis, comparable to that induced by the intact myosin molecule and
HMM (Table 3). The histopathological lesions from Lewis
rats immunized with the S2 fragment are shown in Figure
2d. Severe myocyte necrosis of the myocardium was
observed and the inflammatory cell infiltrate consisted of
mononuclear cells and neutrophils. Control animals immunized with bovine serum albumin or PBS plus adjuvants had no detectable myocardial inflammation (Table
3 and Figure 2f). These results confirmed that the S1
fragment did not induce disease and that the S2 region
strongly induced myocarditis in Lewis rats.
For localization of myocarditic epitope(s) in the LMM
tail fragment of the myosin rod, 49 overlapping 18-mer
peptides that span the LMM region of the cardiac myosin
molecule were synthesized (Table 1) based on published
sequences 38 Because no single LMM peptide could
induce disease, the LMM peptides were tested for myocarditis as eight peptide groups with six consecutive
peptides comprising each LMM peptide group (Table 3).
The LMM peptide group containing peptides 1 to 6 induced moderate inflammation in only one of nine animals
indicating a very minor pathogenic epitope (Table 3).
However, the peptide group containing LMM peptides 19
to 24 induced moderate myocarditis in 45% (5 of 11) of
the animals tested (Table 1, Figure 2e). LMM peptides 19
to 24 corresponded to amino acid residues 1529 to 1611
in HCM. Although, myocarditis was induced by the LMM
19- to 24-peptide group in -50% of the rats, severity was
less than that induced by intact cardiac myosin, HMM, or
S2 subfragments, suggesting that the site in LMM may
not be a dominant myocarditic region for Lewis rats. By
comparing the different regions of the cardiac myosin
molecule in a single study, it allowed us to identify the
most and the least myocarditic regions in the Lewis rat
model and to put these epitopes in perspective with
disease.

Cardiac Myosin-Induced Valvulitis in Lewis Rats
Valve tissue from Lewis rats immunized with HCM and its
subfragments was obtained and examined histopathologically for the presence of inflammatory cells (ie, valvulitis). Forty-three percent of Lewis rats immunized with
HCM and 46% of rats given RCM developed valvulitis
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Table 4.

Induction of Valvulitis in Lewis Rats by
Immunization with Cardiac Myosin, Myosin
Subfragments, or LMM Peptides
Immunogen

Whole molecule
Human cardiac myosin
Rat cardiac myosin
Subfragments of HCM
HMM

S1
S2
Related molecules
Human skeletal myosin
Light meromyosin peptides
LMM peptides 1--B
LMM peptides 7-12
LMM peptides 13-18
LMM peptides 19-24
LMM peptides 25-30
LMM peptides 31-36
LMM peptides 37-42
LMM peptides 43-49
Controls
Bovine serum albumin
PBS + adjuvants

Valvulitis'
(positive/total)
10/23
6/13
4/5
0/4
2/3
0/6
0/6
0/6
0/6
0/11
0/6
2/6
2/4
2/6
0/6
0/34

'Presence of inflammatory cells in valve tissue were indicated as
shown in Figure 3. The level of valvulitis was similar in peptide groups
31 to 36, 37 to 42, and 43 to 49. These peptide groups produced a
similar valvulitis that was seen as cellular infiltration at the valvular
surface endothelium. In some instances, the valvulitis was more severe
for the whole cardiac myosin molecule.

(Table 4). Although not every rat that developed myocarditis developed valvulitis, at least half of the rats that
developed myocarditis developed valvulitis. The valvular
inflammation was characterized histopathologically as
the presence of cellular infiltrates composed primarily of
mononuclear cells within valve tissue (Figure 3, A and B).
Skeletal myosin did not induce valvular inflammation (Table 4).

Localization of Valvulitis-Inducing Fragments of
Cardiac Myosin
Immunization with the cardiac HMM subfragment produced valvulitis in four of five animals (Table 4, Figure 3C)
and immunization with S2 produced valvulitis in two of
three animals (Table 4, Figure 3~). Using groups of synthetic peptides (Table 1), three valvulitis-inducing
epitopes were discovered in the LMM region of HCM
(Table 4). One-third of Lewis rats immunized with LMM
peptides 31 to 36 developed valvulitis (Table 4, Figure
3E). LMM groups containing peptides 37 to 42 (Table 4,
Figure 3F) and 43 to 49 (Table 4, Figure 3G) also induced
valvulitis in two of four and two of six animals, respectively. Control rats immunized with bovine serum albumin
plus adjuvants or PBS plus adjuvants had no detectable
valvular inflammation (Table 4, Figure 3H). Cells with

caterpillar nuclei characteristic of Anitschkow cells,
present in the valves of patients with rheumatic fever,35
could be found scattered throughout the valves of Lewis
rats immunized with cardiac myosin, HMM, or S2 subfragments, and LMM peptides 31 to 36, 37 to 42, and 43
to 49 (Figure 4).
In summary, valvulitis-producing epitopes in cardiac
myosin were located in the rod region. However, the
epitopes in LMM that produced myocarditis (residues
1529 to 1611) were located in a different region from
those producing valvulitis (residues 1685 to 1936). However, both myocarditis and valvulitis were produced by
the HMM and S2 subfragments, but not by the S1 subfragment, suggesting that the most pathogenic epitope is
in the S2 subfragment.

Lymphocytes Infiltrating Hearts in Myocarditis
and Valvulitis Proliferate to Group A
Streptococcal M5 Pep tides
Lymphocytes isolated from hearts after induction of cardiac myosin-induced inflammatory heart disease were
reacted with streptococcal M5 protein peptides to determine the responsiveness of myosin-sensitized lymphocytes to streptococcal M protein. Lymphocytes tested
were isolated from inflamed hearts from four rats showing
clinical signs of myocarditis. Lymphocytes from the myocardial infiltrate proliferated to four M5 peptides including
a group of overlapping peptides in the B repeat region of
the streptococcal M protein including M5 peptides B1A,
B 1B, B 1B2 that indicated stimulation indices of >2.0
(Figure 5). Also elevated were two peptides in the C
repeat region including C1C2 and C3. These data provide
evidence that streptococcal M protein cross-reacts with
myosin-sensitized T cells in hearts developing inflammatory
heart disease such as myocarditis and valvulitis.

Discussion
Herein we report an animal model of valvular heart disease that to our knowledge has not been described. In
addition, our novel observations in the Lewis rat show that
cardiac myosin-induced valvular heart disease resembled valve disease in rheumatic fever. Recently, we have
shown that streptococcal recombinant M6 protein produced a striking cellular infiltration of the valve with focal
lesions in myocardium. 17 In the M protein-induced valvulitis, the cellular infiltrates entered through the valve surface suggesting that the valve endothelium is an important location for entry of inflammatory cells rather than
from myocardium. However, in the valvulitis associated
with cardiac myosin-induced myocarditis, cellular infiltrates were often observed in the myocardium adjacent to
the valve. The evidence also suggests that sensitivity of

Figure 3. Histopathological features of autoimmune valvulitis in Lewis rats. Animals were immunized with HeM (A). RCM (B). HMM fragment of HeM (el, S2
fragmentofHCM CD), LMM peptide group 31 to 36 (E). L\1M peptide group 37 to 42 (F), LMM peptide group 43 to 49 (G), or PHS plus adjuvant, (H). Mononuclear
cell infiltrates can be distinguished in the valves of Lewis rats immunized with human or ReM, HM.'VI fragment, S2 fragment of HCM. or L~!J'vl peptide groups (A-G).
No mononuclear cell infiltrates could be detected in valves from control animals (H). Original magnifications: x400 (A-F): X200 (G and Hl.
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Figure 4. Presence of Anitschkow-like cell:, in valves from Lewis rats immunized with HMM from HCM. In addition to inflammatory cell infiltrates. cells
with caterpillar nuclei morphology were observed (arrowheads). The
Anitschkow-like cells shown in the figure are cut longitudinally and the
condensed chromatin gives the appearance of a caterpillar. Cells with caterpillar nuclei were observed in valves from rats inlI11Unized with intact HeM,
RCM. and HCM subfragments, and LMM peptides.

Lewis rats to valvular heart disease is novel and will be
useful to investigate the pathogenesis of rheumatic and
immune-mediated valvular heart disease.
Using rodent models, the role of cardiac myosin as an
autoantigen in the pathogenesis of autoimmune myocarditis has been well established 8,9,11-13,394D Myocarditis
can be induced by cardiac myosin in A/J mice,8,12
BALB/c mice,3941 and in Lewis rats 9 ,13 However,
C57BL/6 mice are resistant to myosin-induced myocarditis. Exposure of cardiac myosin in the heart may be an
important event leading to the onset of disease in the
susceptible host 42 Evidence has shown that in normal
myocardium myosin-class II major histocompatibility an3
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Streptococcal M protein Peptides
Figure 5. Reaction of lymphocytes infiltrating hearts in cardiac myosininduced myocarditis and valvulitis proliferated to group A streptococcal M'1
peptides. Lymphocytes from the myocardial infiltrate proliferated to four 1'.15
peptides including M5 peptides ilIA, BIB, and R1B2 with stimulation indices
of > 2.0. Also with elevated stimulation indices \vere t\VO peptides in the C
repeat region, CIC2 and C3. These data provide evidence that streptococcal
M protein cross-reacts with myosin sensitized T cells in hearts developing
inflammatory heart disease.

tigen complexes are present before the induction of autoimmune myocarditis 43 Induction of myocarditis is seen
only with cardiac myosin and not skeletal myosin B
Unique epitopes within cardiac myosin have been described to produce myocarditis. Myocarditis was induced by amino acid residues 334 to 352, located in the
S1 region of A/J mouse cardiac myosin, 11 residues 736 to
1032 in BALB/c cardiac myosin,41 acetylated residues
614 to 643 of RCM-produced disease in BALB/c mice,35
residues 1070 to 1165 of porcine cardiac myosin-induced disease in Lewis rats,38 residues 1107 to 1186 in
the Lewis rat,44 and acetylated Lewis rat LMM region
residues 1539 to 1555. 13 Our study in Lewis rats suggests that epitopes within the LMM region produce valvulitis whereas the most severe myocarditis was produced by the S2 region of cardiac myosin.
We have found both CD4+ and CD8+ T cells present
in valves and myocardium of cardiac myosin-induced
myocarditis and valvulitis (data not shown). This is similar
to what we have found in human rheumatic heart disease 45 The data also link epitopes of streptococcal M
protein and cardiac myosin together because myosinsensitized lymphocytes from inflamed hearts proliferated
to several streptococcal M protein peptides (Figure 5).
This further supports the hypothesis that the Lewis rat is
similar to the human, because T cells isolated from valves
of humans with rheumatic heart disease proliferate to a
similar group of peptides of streptococcal M5 protein 34
The homology and a-helical coiled-coil structure shared
between M protein and the cardiac myosin rod is significant enough that both produce inflammatory heart disease in Lewis rats. Although many M protein epitopes
have been shown to be cross-reactive with myosin, only
streptococcal M protein peptides sharing sequence homology with cardiac myosins produced myocardial inflammation in mice. 7 .23 Repeated regions of M proteins
that share homology with only cardiac myosins may
break tolerance to cardiac myosin and induce myocardial disease. 23
Because cardiac myosin is not known to be present in
the valve or expressed extracellularly in normal heart,
how mimicry of cardiac myosin produces myocarditis
and valvular heart disease is an important question. Our
studies suggest that laminin may link myosin with the
valve through cross-reactivity between the a-helical
structures. Recently, a cytotoxic anti-myosin/anti-streptococcal monoclonal antibody from rheumatic carditis was
shown to recognize laminin, an extracellular matrix a-helical coiled-coil protein that is an integral part of the valve
structure as well as present in the extracellular matrix
surrounding the cardiomyocyte. 16 .20 .46 Evidence presented in previous work supports the hypothesis that
laminin, present in the basement membrane of the valve
and secreted by endothelial cells, is a target of crossreactive anti-myosin/anti-streptococcal antibody. Laminin
present in valves and myocardium may cross-react with
anti-myosin/anti-Iaminin T cells and antibody that recognize M protein, myosin, and laminin. Because cardiac
myosin is an intracellular molecule, peptides of it may be
43
presented to T cells during turnover in cardiac tissues
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Exposure of cardiac myosin in damaged regions of the
heart may also lead to inflammatory heart disease.
A systematic approach was used to identify cardiac
myosin epitopes responsible for myocarditis and valvulitis. Valvulitis and myocarditis were observed in Lewis rats
given the S2 fragment and HMM. In LMM, different
groups of peptides produced valvulitis (residues 1685 to
1936) or myocarditis (residues 1529 to 1611). Three different LMM regions (amino acids 1685 to 1767, 1763 to
1846, and 1842 to 1936) were involved in production of
valvulitis in the rats. The incidence of valvulitis induced by
the cardiac myosin subfragments and LMM peptide
groups was decreased when compared to intact cardiac
myosin. This suggests that the valvulitis-inducing
epitopes in cardiac myosin may act in concert to produce
valvular inflammation. The present studies provide a direct link between cardiac myosin and valvular inflammation suggesting that exposure of cardiac myosin may
actively contribute to valvulitis during development of
rheumatic heart disease. Collectively, our results demonstrate that myocarditic epitopes for Lewis rats are located
within the rod region of the cardiac myosin molecule in S2
and LMM with the most pathogenic epitopes in S2. The
myocarditis- and valvulitis-producing epitopes in the
LMM region could be separated and were distinctly different and in two separate regions of the molecule.
Our results demonstrated that myocarditis induced by
self antigen RCM was indistinguishable from that induced
by HCM. Rat cardiac a-myosin (dominant isoform expressed in adult rat heart) and human cardiac i3-myosin
(dominant isoform expressed in human ventricle tissue)
are 93% identical and 98% homologous at the amino acid
sequence level. Mimicry of epitope(s) between HCM and
RCM was sufficient to produce severe disease. Regardless of the source of cardiac myosin, myocarditis and
valvulitis were induced in Lewis rats and multiple
epitopes seemed to contribute to both diseases. The
Lewis rat model of inflammatory heart disease will be a
powerful tool for further investigation of the immunopathogenesis of human myocarditis and rheumatic valvulitis.

Acknowledgments
We thank Ms. Janet Heuser and Ms. Michelle Smart for
expert technical assistance; and Dr. Ken Jackson and
the W. K. Warren of the Molecular Biology Resource
Facility at the University of Oklahoma Health Sciences
Center for synthesis of the human cardiac light meromyosin and group A streptococcal M5 peptides.

References
Huber SA, Gauntt CJ, Sakkinen P: Enteroviruses and myocarditis:
viral pathogenesis through replication. cytokine induction, and immunopathogenicity Adv Virus Res 1998,5135-80
2. Cunningham M: Pathogenesis of group A streptococcal infections.
Clin Microbiol Rev 2000,13470-511
3. Bachmaier K, Neu N, de la Maza L, Pal S, Hessel A, Penninger JM:
Chlamydia infections and heart disease linked through antigenic
mimicry. Science 1999, 2831335-1339

4. Brown CA, O'Connell JB: Myocarditis and idiopathic dilated cardiomyopathy. Am J Med 1995, 99:309-314
5 Cunningham MW. Hall NK, Krisher KK, Spanier AM: A study of monoclonal antibodies against streptococci and myosin. J Immunol 1985,
136293-298
6. Cunningham MW, Swerlick RA: Polyspecificity of antistreptococcal
murine monoclonal antibodies and their implications in autoimmunity.
J Exp Med 1986, 164:998-1012
7. Cunningham MW, Antone SM, Smart M, Liu R, Kosanke S: Molecular
analysis of human cardiac myosin-cross-reactive B- and T-cell
epitopes of the group A streptococcal M5 protein. Infect Immun 1997,
653913-3923
8. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW:
Cardiac myosin induces myocarditis in genetically predisposed mice.
J Immunol 1987, 139:3630-3636
9. Kodama M, Matsumoto Y, FUjiwara M, Massani M. Izumi T, Shibota A:
A novel experimental model of giant cell myocarditis induced in rats
by immunization with cardiac myosin fraction. Clln Immunol Immunopathol 1991. 57:250-262
10. Neu N, Beisel KW, Traystman MD, Rose NR, Craig SW: Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to coxsackievirus B3 induced myocarditis. J Immunol 1987,
1382488-2492
11 Donermeyer DL, Beisel KW, Allen PM, Smith SC Myocarditis-inducing epitope of myosin binds constitutively and stably to I-A K on
antigen presenting cells in the heart J Exp Med 1995, 182:12911300
12. Smith SC, Allen PM Myosin-induced acute myocarditis is a T cell
mediated disease. J Immunol 1991, 147:2141-2147
13. Wegmann KW, Zhao W, Griffin AC, Hickey WF: Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. J Immunol
1994, 153:892-900
14. Krisher K, Cunningham MW: Myosin: a link between streptococci and
heart Science 1985, 227413-415
15 Adderson EE, Shikhman AR, Ward KE, Cunningham MW: Molecular
analysis of polyreactive monoclonal antibodies from rheumatic
carditis: human anti-N-acetyl-glucosamine/anti-myosin antibody V region genes. J Immunol 1998, 161 :2020-2031
16. Galvin JE, Hemric ME. Ward K, Cunningham M Cytotoxic monoclonal
antibody from rheumatic carditis reacts with human endothelium:
implications in rheumatic heart disease. J Clin Invest 2000,106:217224
17. Quinn A, Kosanke S, Fischetti VA, Factor SM, Cunningham M: Induction of autoimmune valvular heart disease by recombinant streptococcal M protein. Infect Immun 2001, 694072-4078
18. Shikhman AR, Greenspan NS, Cunningham MW: A subset of mouse
monoclonal antibodies cross-reactive with cytoskeletal proteins and
group A streptococcal M proteins recognizes N-acetyl-beta-D-glucosamme. J Immunol1993, 151:3902-3913
19. Malkiel S, Liao L Cunningham MW, Diamond B T-cell-dependent
antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin. Infect Immun 2000, 68:5803-5808
20. Cunningham MW, Antone SM, Gulizia JM, McManus BM, Fischetti
VA, Gauntt CJ: Cytotoxic and viral neutralizing antibodies cross react
with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci USA 1992, 89:1320-1324
21 Huber SA, Moraska A, Cunningham M: Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A
streptococci. Proc Nail Acad SCI USA 1994, 91 :5543-5547
22. Huber S, Polgar J, Moraska A, Cunningham M, Schwimmbeck P,
Schultheiss P: T lymphocyte responses in CVB3-induced murine
myocarditis. Scand J Infect Dis 1993. 88(Suppl):S67-S78
23. Huber SA, Cunningham MW: Streptococcal M protein peptide with
similarity to myosin induces CD4+ T cell-dependent myocarditis in
MRL/++ mice and induces partial tolerance against coxsakieviral
myocarditis. J Immunol 1996, 156:3528-3534
24. Rose N: Viral damage or 'molecular mimicry'-placing the blame in
myocarditis. Nat Med 2000, 6:631-632
25. Honwitz MS, La Cava A, Fine C, Rodriguez E, lIic A. Sarvetnick N:
Pancreatic expression of interferon-gamma protects mice from lethal

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

306

Galvin et al

AJPJanliary 2002, Vol. 16(), No.1

26

27.

28.

29.

30.

31.

32.

33.

34.

35.

coxsackieVirus B3 infection and subsequent myocarditis. Nat Med
2000, 6:693-697
Liao L, Sindhwani R, Rojkind M, Factor S, Leinwand L, Diamond B:
Antibody-mediated autoimmune myocarditis depends on genetically
determined target organ sensitivity. J Exp Med 1995, 187:1123-1131
Gauntt C, Arizpe H, Higdon A, Bowers D, Rozek M, Crawley R:
Molecular mimicry, anti-coxsacklevirus B2 neutralizing monoclonal
antibodies and myocarditis. J Immunol 1995, 154:2983-2995
Gauntt CJ, Arizpe HM, Higdon AL. Rozek MM, Crawley R, Cunningham MW: Anti-Coxsackievirus B3 neutralizing antibodies with pathological potential. Eur Heart J 1991, 12:124-129
Gauntt CJ, Higdon AL. Arizpe HM, Tamayo MR, Crawley R, Henkel
RD, Pereira ME, Tracy SM, Cunningham MW: Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute
to CVB3-induced murine myocarditis. Clin Immunol Immunopathol
1993,68129-134
Cunningham MW, McCormack JM, Talaber LR, Harley JB, Ayoub EM,
Muneer RS, Chun LT, Reddy DV: Human monoclonal antibodies
reactive with antigens of the group A streptococcus and human heart
J Immunol 1988, 141:2760-2766
Cunningham MW, McCormack JM, Fenderson PG, Ho MK, Beachey
EH, Dale JB: Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-L YSSER-LYS-GLN in M protein. J Immunol 1989, 1432677-2683
Kaplan MH, Bolande R, Ratika L, Blair J: Presence of bound Immunoglobulins and complement in the myocardium in acute rheumatic
fever. N Engl J Med 1964,271637-645
Gulizia JM, Cunningham MW, McManus BM: Immunoreactivity of
anti-streptococcal monoclonal antibodies to human heart valves. Evidence for multiple cross-reactive epitopes. Am J Pathol 1991, 138
285-301
Guilherme L. Cunha-Neto E, Coelho V, Snitcowsky R. Pomerantzeff
PMA, Assis RV, Pedra F, Neumann J, Goldberg A. Patarroyo ME,
Pileggi F, Kalil J: Human heart-filtrating T cell clones from rheumatic
heart disease patients recognize both streptococcal and cardiac
proteins. Circulation 1995, 92:415-420
Liao L, Sindhwani R, Leinwand L, Diamond B, Factor S: Cardiac

36

37.

38.

39.
40.

41.
42.

43.

44.

45.

46.

",-myosin heavy chains differ in their induction of myocarditis: identification of pathogenic epitopes. J Clin Invest 1993, 92:2877-2882
McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt
CJ, Klingel KE, Beisel KW, Kandolf R Direct myocardial injury by
enterovirus: a central role In the evolution of murine myocarditis. Clin
Immunol Immunopathol 1993,68:159-169
Smith SC, Allen PM: Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci USA 1992. 89:
9131-9135
Kohno K, Takagaki Y, Nakajima Y, Izumi T Advantage of recombinant
technology for the identification of cardiac myosin epitope of severe
autoimmune myocarditis in Lewis rats. Jpn Heart J 2000. 41:67-77
Stolierman GH Rheumatic Fever and Streptococcal Infection. New
York, Grune and Stratton, 1975
Tobacman LS, Adelstein RS. Enzymatic comparisons between light
chain isozymes of human cardiac myosin subfragment-1 J Bioi
Chem 1984, 259:11226-11230
Margossian SS, Lowey S Preparation of myosin and its subfragments
from rabbit skeletal muscle. Methods Enzymol 1982, 85:55-71
Jaenicke T, Diederich KW. Haas W, Scheich J, Lichter P. Pfordt M,
Bach A, Vosberg HP: Complete sequence of human f3 myosin.
Genomics 1990, 8:194-207
Pummarer CL, Luze K, Grassl G. Bachmaler K, Offner F, Lenz OM,
Zamborelli TJ, Penninger JM, Neu N: Identification of cardiac myosin
peptides capable of inducing autoimmune myocarditis in BALB/c
mice. J Clin Invest 1996, 97:2057-2062
Inomata T, Hanawa T, Mihanlshi E, Yajima S, Nakayama T, Maita M,
Kodama T Izumi A, Shibata A, Abo T Localization of porcine cardiac
myosin epitopes that induce experimental autoimmune myocarditis.
Circ Res 1995, 76726-733
Roberts S, Kosanke S, Dunn ST, Jankelow 0, Duran CMG, Cunningham M: Immune mechanisms in rheumatic carditis: focus on valvular
endothelium. J Infect Dis 2001, 183:507-511
Antone SM. Adderson EE, Mertens NMJ, Cunningham MW: Molecular
analysis of V gene sequences encoding cytotoxic anti-streptococcal/
anti-myosin monoclonal antibody 36.2.2 that recognizes the heart cell
surface protein laminin. J Immunol 1997, 159:5422-5430

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

